Nicholas Haft
Fondatore presso Delix Therapeutics, Inc.
Posizioni attive di Nicholas Haft
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Delix Therapeutics, Inc.
 Delix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Delix Therapeutics, Inc. is a clinical-stage neuroscience company that focuses on developing novel neuroplasticity-promoting therapeutics to treat neuropsychiatric and neurological disorders. The company's compounds are small molecules that can induce structural and functional neural changes in targeted areas of the brain. Delix is pioneering a new class of fast-acting outpatient pharmacotherapies and advancing through preclinical and clinical development to bring patients FDA-approved, take-home medicines that will serve several unmet needs. The company is headquartered in Palo Alto, CA, and has subsidiaries in the United States. Delix was founded by David E. Olson, Nick Haft, Nicholas Haft, and Paul A. Conley, and Mark Rus has been the CEO of the company since 2021. | Direttore/Membro del Consiglio | - | - |
| Fondatore | - | - | |
| Amministratore Delegato | - | - | |
| Direttore Finanziario/CFO | - | - | |
| Segretario Aziendale | - | - | |
| Arcos Ventures SPV LLC | Direttore/Membro del Consiglio | 01/04/2015 | - |
| Amministratore Delegato | 01/04/2015 | - |
Storia della carriera di Nicholas Haft
Precedenti posizioni note di Nicholas Haft
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Direttore/Membro del Consiglio | 01/02/2020 | 23/06/2023 |
| Independent Dir/Board Member | 01/02/2020 | 23/06/2023 |
Formazione di Nicholas Haft
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Independent Dir/Board Member | 1 |
Settori
| Consumer Services | 2 |
| Health Services | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Health Services |
| Aziende private | 2 |
|---|---|
| Arcos Ventures SPV LLC | |
Delix Therapeutics, Inc.
Delix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Delix Therapeutics, Inc. is a clinical-stage neuroscience company that focuses on developing novel neuroplasticity-promoting therapeutics to treat neuropsychiatric and neurological disorders. The company's compounds are small molecules that can induce structural and functional neural changes in targeted areas of the brain. Delix is pioneering a new class of fast-acting outpatient pharmacotherapies and advancing through preclinical and clinical development to bring patients FDA-approved, take-home medicines that will serve several unmet needs. The company is headquartered in Palo Alto, CA, and has subsidiaries in the United States. Delix was founded by David E. Olson, Nick Haft, Nicholas Haft, and Paul A. Conley, and Mark Rus has been the CEO of the company since 2021. | Health Technology |
- Borsa valori
- Insiders
- Nicholas Haft
- Esperienza
